Quarterly EPS Estimate For LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stands At $0.12

0

The average EPS estimate for LeMaitre Vascular, Inc. (NASDAQ:LMAT) for the three-month period quarter ended 2016-09-30 stands at $0.12.

The EPS estimates for the stock 7 days ago was$0.12 and for 30 days ago it was $0.12. For 60 and 90 days ago, the stock had EPS estimates of $0.12 and $0.12 respectively. If you look at the latest 7 days and the prior 7 days, if you find that the stock’s EPS estimate changed 0%.

The last 7 days saw 0 upwards EPS revisions on the stock compared to 0 downward EPS revisions over the same period. In the last 30 and 60 days, the number of upward EPS estimates revisions were 0 and 0, respectively. That compared with upward EPS estimates revisions of 2 and 2 for the last 90 and 120 days, respectively.

As for the last 18 days, the number of upward and downward EPS revisions on the stock were 2 and 0 respectively.

Earnings Surprises

LeMaitre Vascular, Inc. (NASDAQ:LMAT) posted actual EPS of $0.11 on 2016-05-02 for the quarter ended 1. That compared with the average EPS estimate for the quarter of $0.12, based on a total of 3 EPS estimates on the stock.

As such, the EPS surprise in dollar terms per share was $0.01 and percentage surprise was 10%. That works out to standard deviation of 0 if you take into account all the EPS estimates before the actual EPS report.

Quarterly Sales Estimates

The mean sales estimate for LeMaitre Vascular, Inc. (NASDAQ:LMAT) for the fiscal year 2016 is $22.716 while the median sales estimate is $22.76. The mean and median sales estimates are worked out based on the accounts of 3 analysts covering the stock for the cited fiscal year.

The highest sales estimate for LeMaitre Vascular, Inc. (NASDAQ:LMAT) is $22.8 while the lowest sales estimate is $22.59. That works out to standard deviation of 0.111%.

In the past week, 3 analysts have raised their sales estimates on the stock while 3 analysts have trimmed their sales estimates. That works out a percentage change in mean sales estimate of 0% from the past week.

In the last one month, 3 analysts have increased their sales estimates on the stock while 3 analysts have reduced their sales estimates. With that, you find that the percentage change in mean sales estimate since one month ago stands at 0%.

Since three months ago, 3 analysts have raised their sales estimates for LeMaitre Vascular, Inc. (NASDAQ:LMAT) and 3 have lowered their sales estimates for the stock. Therefore, the percentage change in mean sales estimate for the stock from the last three months is 1.774%.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 11 times, 1 visits today)